Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Sodium-glucose cotransporter 2 inhibitors and inflammation in chronic kidney disease: Possible molecular pathways
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-08-07
DOI
10.1002/jcp.26851
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sodium–glucose transporter as a novel therapeutic target in disease
- (2018) Yui Yamazaki et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Direct cardiovascular impact of SGLT2 inhibitors: mechanisms and effects
- (2018) Abdullah Kaplan et al. HEART FAILURE REVIEWS
- Oxidative stress induces renal failure: A review of possible molecular pathways
- (2018) Habib Yaribeygi et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Empagliflozin rescues diabetic myocardial microvascular injury via AMPK-mediated inhibition of mitochondrial fission
- (2018) Hao Zhou et al. Redox Biology
- Canagliflozin, a sodium glucose cotransporter 2 inhibitor, attenuates obesity-induced inflammation in the nodose ganglion, hypothalamus, and skeletal muscle of mice
- (2017) Farhana Naznin et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Cardiovascular disease prevention strategies for type 2 diabetes mellitus
- (2017) Niki Katsiki et al. EXPERT OPINION ON PHARMACOTHERAPY
- Oxidative Stress, Inflammation, and Vascular Aging in Hypertension
- (2017) Tomasz J. Guzik et al. HYPERTENSION
- SGLT2 Inhibitors as a Therapeutic Option for Diabetic Nephropathy
- (2017) Daiji Kawanami et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Non-alcoholic fatty liver disease in patients with type 2 diabetes mellitus: Effects of statins and antidiabetic drugs
- (2017) Niki Katsiki et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- The association between inflammation, obesity and elevated blood pressure in 16–25-year-old females
- (2017) A K Subasinghe et al. JOURNAL OF HUMAN HYPERTENSION
- Arterial spin labeling MRI is able to detect early hemodynamic changes in diabetic nephropathy
- (2017) José María Mora-Gutiérrez et al. JOURNAL OF MAGNETIC RESONANCE IMAGING
- Toll-like receptor-4 signaling mediates inflammation and tissue injury in diabetic nephropathy
- (2017) Giacomo Garibotto et al. JOURNAL OF NEPHROLOGY
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- Efficacy of Additional Canagliflozin Administration to Type 2 Diabetes Patients Receiving Insulin Therapy: Examination of Diurnal Glycemic Patterns Using Continuous Glucose Monitoring (CGM)
- (2017) Mihoko Matsumura et al. Diabetes Therapy
- SGLT2 Inhibition by Empagliflozin Promotes Fat Utilization and Browning and Attenuates Inflammation and Insulin Resistance by Polarizing M2 Macrophages in Diet-induced Obese Mice
- (2017) Liang Xu et al. EBioMedicine
- Factors Affecting Canagliflozin-Induced Transient Urine Volume Increase in Patients with Type 2 Diabetes Mellitus
- (2016) Hiroyuki Tanaka et al. ADVANCES IN THERAPY
- The Effect of Short-Term Hyperglycemia on the Innate Immune System
- (2016) Nagham Jafar et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Cardiovascular effects of dapagliflozin in patients with type 2 diabetes and different risk categories: a meta-analysis
- (2016) Christian Sonesson et al. Cardiovascular Diabetology
- Sodium Glucose Cotransporter 2 Inhibitors in the Treatment of Diabetes Mellitus
- (2016) Hiddo J.L. Heerspink et al. CIRCULATION
- Pharmacodynamic Effects of Single and Multiple Doses of Empagliflozin in Patients With Type 2 Diabetes
- (2016) Tim Heise et al. CLINICAL THERAPEUTICS
- Potential role of sodium glucose cotransporter 2 inhibitors in the treatment of hypertension
- (2016) Ilkka Tikkanen et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Editorial: Can Glucagon Like Peptide 1 (GLP1) Agonists or Sodium-Glucose Co-Transporter 2 (SGLT2) Inhibitors Ameliorate Non-Alcoholic Steatohepatitis in People with or without Diabetes?
- (2016) Vasilios G. Athyros et al. Current Vascular Pharmacology
- Anti-inflammatory Agents in the Treatment of Diabetes and Its Vascular Complications
- (2016) Rena M. Pollack et al. DIABETES CARE
- SGLT2 Inhibitors and the Diabetic Kidney
- (2016) Paola Fioretto et al. DIABETES CARE
- The beneficial effects of empagliflozin, an SGLT2 inhibitor, on atherosclerosis in ApoE −/− mice fed a western diet
- (2016) Ji Hye Han et al. DIABETOLOGIA
- Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications
- (2016) Caroline Pereira Domingueti et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors
- (2016) Matthew R. Weir POSTGRADUATE MEDICINE
- Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitor Increases Circulating Zinc-Α2-Glycoprotein Levels in Patients with Type 2 Diabetes
- (2016) Xin Liao et al. Scientific Reports
- Nutritional Biomarkers, Gene-Diet Interaction, and Risk Factors for Type 2 Diabetes
- (2016) Ju-Sheng Zheng et al. Journal of Diabetes Research
- Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
- (2016) Nathan R. Hill et al. PLoS One
- Effect of Sodium-Glucose Co-Transporter 2 Inhibitor, Dapagliflozin, on Renal Renin-Angiotensin System in an Animal Model of Type 2 Diabetes
- (2016) Seok Joon Shin et al. PLoS One
- The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes Mellitus
- (2015) Volker Vallon Annual Review of Medicine
- Renal Denervation Prevents Immune Cell Activation and Renal Inflammation in Angiotensin II–Induced HypertensionNovelty and Significance
- (2015) Liang Xiao et al. CIRCULATION RESEARCH
- Prevention of oxidative stress, inflammation and mitochondrial dysfunction in the intestine by different cranberry phenolic fractions
- (2015) Marie-Claude Denis et al. CLINICAL SCIENCE
- Sodium-glucose cotransport
- (2015) Søren Brandt Poulsen et al. CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION
- Glomerular haemodynamic profile of patients with Type 1 diabetes compared with healthy control subjects
- (2015) M. Škrtić et al. DIABETIC MEDICINE
- Angiotensin II-induced hypertensive renal inflammation is mediated through HMGB1-TLR4 signaling in rat tubulo-epithelial cells
- (2015) Anand R. Nair et al. EXPERIMENTAL CELL RESEARCH
- Empagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2 Exerts Anti-Inflammatory and Antifibrotic Effects on Experimental Diabetic Nephropathy Partly by Suppressing AGEs-Receptor Axis
- (2015) A. Ojima et al. HORMONE AND METABOLIC RESEARCH
- A Nonpeptide Angiotensin II Type 2 Receptor Agonist Prevents Renal Inflammation in Early Diabetes
- (2015) Luis C. Matavelli et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Inflammatory Cytokines in Diabetic Nephropathy
- (2015) Javier Donate-Correa et al. Journal of Diabetes Research
- Diabetic Retinopathy: Vascular and Inflammatory Disease
- (2015) F. Semeraro et al. Journal of Diabetes Research
- Improved Glucose Control With Weight Loss, Lower Insulin Doses, and No Increased Hypoglycemia With Empagliflozin Added to Titrated Multiple Daily Injections of Insulin in Obese Inadequately Controlled Type 2 Diabetes
- (2014) Julio Rosenstock et al. DIABETES CARE
- Modeling effects of SGLT-2 inhibitor dapagliflozin treatment versus standard diabetes therapy on cardiovascular and microvascular outcomes
- (2014) J. Dziuba et al. DIABETES OBESITY & METABOLISM
- Obesity and Its Metabolic Complications: The Role of Adipokines and the Relationship between Obesity, Inflammation, Insulin Resistance, Dyslipidemia and Nonalcoholic Fatty Liver Disease
- (2014) Un Jung et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dapagliflozin Added to Usual Care in Individuals with Type 2 Diabetes Mellitus with Preexisting Cardiovascular Disease: A 24-Week, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study with a 28-Week Extension
- (2014) Lawrence A. Leiter et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- The Sodium-Glucose Co-Transporter 2 Inhibitor Empagliflozin Improves Diabetes-Induced Vascular Dysfunction in the Streptozotocin Diabetes Rat Model by Interfering with Oxidative Stress and Glucotoxicity
- (2014) Matthias Oelze et al. PLoS One
- Sodium Glucose Co-Transporter-2 (SGLT2) Inhibitors: A Review of Their Basic and Clinical Pharmacology
- (2014) Sanjay Kalra Diabetes Therapy
- Sodium Glucose Transport 2 (SGLT2) Inhibition Decreases Glomerular Hyperfiltration
- (2013) Robert C. Stanton CIRCULATION
- Molecular mechanisms in the pathogenesis of diabetic nephropathy: An update
- (2013) Mandeep Kumar Arora et al. VASCULAR PHARMACOLOGY
- Inflammation and the pathogenesis of diabetic nephropathy
- (2012) Jun Wada et al. CLINICAL SCIENCE
- Autocrine modulation of glucose transporter SGLT2 by IL-6 and TNF-α in LLC-PK1 cells
- (2012) M. I. Maldonado-Cervantes et al. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
- Inflammation in Diabetic Nephropathy
- (2012) Andy K. H. Lim et al. MEDIATORS OF INFLAMMATION
- A Glimpse of Various Pathogenetic Mechanisms of Diabetic Nephropathy
- (2011) Yashpal S. Kanwar et al. Annual Review of Pathology-Mechanisms of Disease
- Toll-Like Receptor 4 Promotes Tubular Inflammation in Diabetic Nephropathy
- (2011) M. Lin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy
- (2011) Juan F. Navarro-González et al. Nature Reviews Nephrology
- Relationship between Oxidative Stress and Inflammatory Cytokines in Diabetic Nephropathy
- (2010) Ahmed A. Elmarakby et al. Cardiovascular Therapeutics
- Oxidative stress, inflammation, and cancer: How are they linked?
- (2010) Simone Reuter et al. FREE RADICAL BIOLOGY AND MEDICINE
- Association between C-Reactive Protein and Adiposity in Women
- (2009) Murielle Bochud et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Role of the renin–angiotensin system in vascular inflammation
- (2008) Chiara Marchesi et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started